Pacira BioSciences (PCRX) Cash from Operations (2010 - 2026)
Pacira BioSciences (PCRX) posted Cash from Operations of $57.46 million for Q2 2026, up 378.4% from $12.01 million a year earlier and up 123.8% from the prior quarter.
Powered by 
Analysis
Pacira BioSciences (PCRX) Cash from Operations (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Operations at Pacira BioSciences was $187.66 million, up 39.5% year-over-year; for FY2025, it was $151.99 million, down 19.7% from FY2024.
- Annual Cash from Operations shows a five-year compound annual growth rate of 14.6% (FY2020 to FY2025).
- In prior years, Pacira BioSciences' Cash from Operations was $189.39 million in FY2024 (+22.5%), $154.65 million in FY2023 (+6.5%), $145.27 million in FY2022 (+15.6%) and $125.72 million in FY2021 (+63.2%).
- Quarterly Cash from Operations has run from a low of $12.01 million in Q2 2025 to a high of $60.83 million in Q3 2025 over five years.
- On a year-over-year basis, Cash from Operations increased in four of the last eight quarters, with growth averaging 35.2%.
- The strongest year-over-year quarter for Cash from Operations in the past five years was Q2 2026, with growth of 378.4%; the weakest was Q2 2025, with a decline of 77.4%.
- According to Business Quant data, Cash from Operations for the three prior quarters was $25.68 million (Q1 2026), $43.69 million (Q4 2025) and $60.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 8.62 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.44 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.37 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.88 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.58 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.00 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.57 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 835.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.13 Bn |
| 10 | Pacira BioSciences | 997.55 Mn | 59.58 Mn | 148.24 Mn | 57.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 57.46 Mn |
| Mar 31, 2026 | 25.68 Mn |
| Dec 31, 2025 | 43.69 Mn |
| Sep 30, 2025 | 60.83 Mn |
| Jun 30, 2025 | 12.01 Mn |
| Mar 31, 2025 | 35.46 Mn |
| Dec 31, 2024 | 33.13 Mn |
| Sep 30, 2024 | 53.92 Mn |
| Jun 30, 2024 | 53.24 Mn |
| Mar 31, 2024 | 49.10 Mn |
| Dec 31, 2023 | 47.58 Mn |
| Sep 30, 2023 | 44.44 Mn |
| Jun 30, 2023 | 43.50 Mn |
| Mar 31, 2023 | 19.13 Mn |
| Dec 31, 2022 | 42.04 Mn |
| Sep 30, 2022 | 42.65 Mn |
| Jun 30, 2022 | 29.81 Mn |
| Mar 31, 2022 | 30.78 Mn |
| Dec 31, 2021 | 23.22 Mn |
| Sep 30, 2021 | 60.29 Mn |
API Access
Pacira BioSciences Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=PCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();